Fully Implanted Central Venous Catheter in Oncological Patients: Multiple Case Report
DOI:
https://doi.org/10.36489/saudecoletiva.2025v15i95p15600-15615Keywords:
Central Venous Catheters, Oncology, Nursing, Cancer, Breast cancerAbstract
Objective: to describe the characteristics of cancer patients using fully implanted central venous catheters in an oncology service over a 14-year period of records. Method: multiple case reports based on secondary data from a large hospital. Epi Data software and the Statistical Package for the Social Sciences were used for analysis. Results: 450 catheters were implanted, 76.9% in female patients, mean age of 51.5 years, diagnosed with breast cancer (43.3%), the main reason for catheter implantation was the administration of antineoplastic chemotherapy (63.5%), mean length of stay of 502 days and maximum length of use of 2340 days. The events that led to catheter removal were: infections (3.3%), thrombosis (1.8%) and embolizations (1.8%). Conclusion: patients tolerated the catheter well, with few complications, reflecting the commitment of the care team regarding guidance and continuous care.
References
Santos MO, Lima FCS, Martins LFL, Oliveira JFP, Almeida LM, Cancela MC. Estimativa de Incidência de Câncer no Brasil, 2023-2025. Rev. Bras. Cancerol. 2023; 69(1):e-213700. DOI: 10.32635/2176-9745.RBC.2023v69n1.3700. Available from: https://rbc.inca.gov.br/index.php/revista/article/view/3700/2644 DOI: https://doi.org/10.32635/2176-9745.RBC.2023v69n1.3700
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-249. DOI: 10.3322/caac.21660. Available from: https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.21660 DOI: https://doi.org/10.3322/caac.21660
Cardoso AMG, Wengrover FS, Wurzius A, Pieta MP, Carli RN, et al. Portocath insertion technique: retrospective study & step-by-step surgical description without tunneling in a high-complexity service. Rev Col Bras Cir. 2022; 49(e20223167). DOI: 10.1590/0100-6991e-20223167. Available from: https://www.scielo.br/j/rcbc/a/sS7Yp8NgqHCFKxt7Ksg47Fs/?format=pdf&lang=en DOI: https://doi.org/10.1590/0100-6991e-20223167
Melo JMA, Oliveira PP, Souza RS, Fonseca DFD, Gontijo TF, Rodrigues AB. Prevention and conduct against the Extravasation of antineoplastic chemotherapy: a scoping review. Rev Bras Enferm. 2020 Jun 17;73(4):e20190008. DOI: 10.1590/0034-7167-2019-0008. Available from: https://www.scielo.br/j/reben/a/YBJdCmQjBGJtSRdxv6F4pvD/?format=pdf&lang=en DOI: https://doi.org/10.1590/0034-7167-2019-0008
Capozzi VA, Monfardini L, Sozzi G, Armano G, Butera D, Scarpelli E, et al. Peripherally Inserted Central Venous Catheters (PICC) versus totally implantable venous access device (PORT) for chemotherapy administration: a meta-analysis on gynecological cancer patients. Acta Biomed. 2021;92(5):e2021257. DOI: 10.23750/abm.v92i5.11844. Available from: https://mattioli1885journals.com/index.php/actabiomedica/article/view/11844/10229
Cesar RM, Lage APD, Wainstein A. Follow up of utility and value of totally implantable chemotherapy catheter in 233 brazilian patients receiving chemotherapy to treat cancer. Rev Col Bras Cir. 2023; 50(e20233367). DOI: 10.1590/0100-6991e-20233367-en. Available from: https://www.scielo.br/j/rcbc/a/YVNHrMwXD3sjqxHdMyMKfnr/?format=pdf&lang=en DOI: https://doi.org/10.1590/0100-6991e-20233367-en
Li K, Zhu L, Zhang LY. Correlations between activation, family adaptation, and self-perceived burden in breast cancer patients with an implanted venous access port: A cross-sectional study. Medicine (Baltimore). 2023;102(50:e36443). DOI: 10.1097/MD.0000000000036443. Available from: https://journals.lww.com/md-ournal/fulltext/2023/12150/correlations_between_activation,_family.139.aspx DOI: https://doi.org/10.1097/MD.0000000000036443
Fonseca DF, Olivera PP, Amaral RAC, Nicoli LHS, Silveira EAA, Rodrigues AB. Care protocol with totaly implanted venous catheter: a collective construction. Texto contexto - enferm. 2019; 28(e20180352). DOI: 10.1590/1980-265X-TCE-2018-0352. Available from: https://www.scielo.br/j/tce/a/PYLHjvT8b9fT99WVC5LRnwy/?format=pdf&lang=en DOI: https://doi.org/10.1590/1980-265x-tce-2018-0352
Bailleul A, Fulgencio JP, Vimont S, Mordelet C, Ray B, Lassel L, et al. Risk factors and prognostic significance of infection of totally implantable vascular access port in solid tumor patients: A prospective cohort study. Infect Dis Now. 2023; 53(8):104766. DOI: 10.1016/j.idnow.2023.104766. Available from: https://www.sciencedirect.com/science/article/pii/S2666991923001288?via%3Dihub DOI: https://doi.org/10.1016/j.idnow.2023.104766
Furuhashi S, Morita Y, Ida S, Muraki R, Kitajima R, Suzuki K, et al. Risk Factors for Totally Implantable Central Venous Access Port-related Infection in Patients With Malignancy. Anticancer Res. 2021; 41(3): 1547-1553. DOI: 10.21873/anticanres. Acesso em: 10 jan. 2024. Available from: https://ar.iiarjournals.org/content/41/3/1547.long DOI: https://doi.org/10.21873/anticanres.14914
Jahangiri F, Salek M, Nassiri SJ, Samadi F, Koohian Mohammadabadi M. Results of Port-A-Cath Implantation: A Cross-Sectional Study about a Single Tertiary Cancer Center Experience. Med J Islam Repub Iran. 2022; 15;36:64. DOI: 10.47176/mjiri.36.64. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448478/ DOI: https://doi.org/10.47176/mjiri.36.64
Jiang M, Li CL, Pan CQ, Cui XW, Dietrich CF. Risk of venous thromboembolism associated with totally implantable venous access ports in cancer patients: A systematic review and meta-analysis. J Thromb Haemost. 2020 Sep;18(9):2253-2273. DOI: 10.1111/jth.14930. Available from: https://www.sciencedirect.com/science/article/pii/S1538783622016427?via%3Dihub DOI: https://doi.org/10.1111/jth.14930
Voog E, Campion L, Rusquec P, Bourgeois H, Domont J, Denis F, et al. Totally implantable venous access ports: a prospective long-term study of early and late complications in adult patients with cancer. Support Care Cancer. 2018;26(1):81-89. DOI: 10.1007/s00520-017-3816-3. Available from: https://link.springer.com/article/10.1007/s00520-017-3816-3 DOI: https://doi.org/10.1007/s00520-017-3816-3
Skelton WP 4th, Franke AJ, Welniak S, Bosse RC, Ayoub F, Murphy M, Starr JS. Investigation of Complications Following Port Insertion in a Cancer Patient Population: A Retrospective Analysis. Clin Med Insights Oncol. 2019; 3:1179554919844770. DOI: 10.1177/1179554919844770. Available from: https://journals.sagepub.com/doi/full/10.1177/1179554919844770?rfr_dat=cr_pub++0pubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org
Aziret M, İrkörücü O, Gökler C, Reyhan E, Çetinkünar S, Çil T, et al. Performance of venous port catheter insertion by a general surgeon: a prospective study. Int Surg. 2015; 100 (5): 827-35. DOI: 10.9738/INTSURG-D-14-00214.1. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452970/ DOI: https://doi.org/10.9738/INTSURG-D-14-00214.1
Zerati AE, Wolosker N, de Luccia N, Puech-Leão P. Cateteres venosos totalmente implantáveis: histórico, técnica de implante e complicações. J Vasc Bras. 2017;16(2):128-139. DOI: 10.1590/1677-5449.008216. Available from: https://www.scielo.br/j/jvb/a/hHcgR6bgPdffvg7rtssf9ys/?format=pdf&lang=pt DOI: https://doi.org/10.1590/1677-5449.008216
Lenz H, Myre K, Draegni T, Dorph E. A Five-Year Data Report of Long-Term Central Venous Catheters Focusing on Early Complications. Anesthesiol Res Pract. 2019; 10: 6769506. DOI: 10.1155/2019/6769506. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925808/ DOI: https://doi.org/10.1155/2019/6769506
O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, et al. Healthcare Infection Control Practices Advisory Committee (HICPAC). Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011 May;52(9):e162-93. DOI: 10.1093/cid/cir257. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3106269/ DOI: https://doi.org/10.1093/cid/cir257
Centers for Disease Control and Prevention (CDC). National Healthcare Safety Network (NHSN) Patient Safety Component Manual, Detection and Control of Infectious Diseases. Atlanta, GA, USA, 2024. Available from: https://www.cdc.gov/nhsn/pdfs/pscmanual/pcsmanual_current.pdf
Oliveira PP, Santos VEP, Bezerril MS, Andrade FB, Paiva RM, Silveira EAA. Patient safety in the administration of antineoplastic chemotherapy and of immunotherapics for oncological treatment: scoping review. Texto contexto - enferm. 2019; 28(e20180312). DOI: 10.1590/1980-265X-TCE-2018-0312. Available from: https://www.scielo.br/j/tce/a/NTx6wZsySnCtGNGTRhgNDWv/?format=pdf&lang=en DOI: https://doi.org/10.1590/1980-265x-tce-2018-0312
Oliveira PP. Challenges of quality and patient safety in oncology services. R. Enferm. Cent. O. Min. 2017; 7(eEditorial). DOI: 10.19175/recom.v7i0.2692. Available from: http://seer.ufsj.edu.br/recom/article/view/2692/1815
Viola GM, Szvalb AD, Malek AE, Chaftari AM, Hachem R, Raad II. Prevention of device-related infections in patients with cancer: Current practice and future horizons. CA Cancer J Clin. 2023;73(2):147-163. DOI: 10.3322/caac.21756. Available from: https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.21756 DOI: https://doi.org/10.3322/caac.21756
